NASDAQ:SGMT | Cash Flow Statement | Sagimet Biosciences Inc.

Complete source-backed cash-flow history.

Available history
2022-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$13.95M
2026-03-31-$10.65M-$8.61M$10.22M
2025-12-31-$9.57M-$11.83M$14.36M$0.00
2025-09-30-$12.91M
2025-06-30-$10.39M
2025-03-31-$18.18M-$14.54M$3.41M
2024-12-31-$16.2M-$11.02M$9.85M$0.00
2024-09-30-$14.62M
2024-06-30-$8.12M
2024-03-31-$6.63M-$6.21M$3M$104.85M
2023-12-31-$8.15M-$7.08M-$19.62M$0.00
2023-09-30-$6.35M
2023-06-30-$6.79M
2023-03-31-$6.59M-$7.08M$19.4M-$136,000.00
2022-12-31-$7.2M-$7.45M$5.44M-$55,000.00
2022-09-30-$7.47M
2022-06-30-$7.1M
2022-03-31-$8.74M-$10.8M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$51.04M-$45.65M$4.56M$275,000.00
2024-12-31-$45.57M-$42.44M-$61.68M$104.82M
2023-12-31-$27.88M-$23.77M$12.58M$86.17M
2022-12-31-$30.5M-$24.49M-$32.01M-$73,000.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.